Magnetar Financial’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Magnetar Financial’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$782K	Buy	+26,373	New	+$756K	0.01%	632

Other funds holding LKFT

Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return

Prosight Management Dallas, Texas $515M AUM 2.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Magnetar Financial's LKFT Position: Q3 2026 in Review

Magnetar Financial opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026: 26,373 shares worth $782K. The stake represents 0.01% of the portfolio and ranks #632 among its holdings.

66 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

Magnetar Financial held 26,373 shares of Lakefront Biotherapeutics American Depositary Shares worth $782K as of Q3 2026.
Lakefront Biotherapeutics American Depositary Shares was a new Magnetar Financial position in Q3 2026.
Lakefront Biotherapeutics American Depositary Shares made up 0.01% of Magnetar Financial's portfolio in Q3 2026, its #632 holding.
66 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Magnetar Financial's 13F filing for Q3 2026, filed 13 Nov 2026.